Échelle d’évaluation de la dysplasie épithéliale de l’ovaire

Annales de Pathologie - Tập 31 - Trang 3-10 - 2011
Gautier Chene1,2,3,4, Jacques Dauplat1, Ines Raoelfils2, Yves-Jean Bignon4, Anne Cayre2, Patricia Jaffeux5, Bruno Aublet-Cuvelier5, Christophe Pomel1, Frédérique Penault-Llorca2
1Département de chirurgie, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France
2Département d’anatomopathologie, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France
3Département de gynécologie-obstétrique et médecine de la reproduction, hôpital Nord, CHU de Saint-Étienne, université de Saint-Étienne–Jean-Monnet, 42000 Saint-Étienne, France
4Département d’oncologie moléculaire, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France
5Département d’informations médicales, hôpital Gabriel-Montpied, CHU de Clermont-Ferrand, 63000 Clermont-Ferrand, France

Tài liệu tham khảo

Fathalla, 1971, Incessant ovulation: a factor in ovarian neoplasia?, Lancet, 2, 163, 10.1016/S0140-6736(71)92335-X Fleming, 2006, Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses, Mol Cell Endocrinol, 247, 4, 10.1016/j.mce.2005.09.014 Gusberg, 1984, Ovarian dysplasia, a study of identical twins, Cancer, 54, 1, 10.1002/1097-0142(19840701)54:1<1::AID-CNCR2820540102>3.0.CO;2-9 Salazar, 1996, Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies, J Natl Cancer Inst, 88, 1810, 10.1093/jnci/88.24.1810 Werness, 1999, Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer, Hum Pathol, 30, 151, 10.1016/S0046-8177(99)90269-1 Stratton, 1999, Comparison of prophylactic oophorectomy specimens from carriers and non carriers of a BRCA1 or BRCA2 gene mutation, J Natl Cancer Inst, 91, 626, 10.1093/jnci/91.7.626 Resta, 1993, Morphologic precursors of ovarian epithelial tumors, Obstet Gynecol, 82, 181 Plaxe, 1990, Ovarian intraepithelial neoplasia demonstrated in patients with stage I ovarian carcinoma, Gynecol Oncol, 38, 367, 10.1016/0090-8258(90)90075-V Mittal, 1993, Controlateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions, Int J Gynecol Pathol, 12, 59, 10.1097/00004347-199301000-00008 Tressera, 1998, Histological features of the controlateral ovary in patients with unilateral ovarian cancer: a case control study, Gynecol Oncol, 71, 437, 10.1006/gyno.1998.5185 Nieto, 2001, Ovarian epithelial dysplasia in relation to ovulation induction and nulliparity, Gynecol Oncol, 82, 344, 10.1006/gyno.2001.6227 Chene, 2009, Ovarian epithelial dysplasia after ovulation induction: time and dose effect, Human Reprod, 24, 132, 10.1093/humrep/den358 Chene, 2009, Ovarian epithelial dysplasia and prophylactic oophorectomy for genetic risk, Int J Gynecol Cancer, 19, 65, 10.1111/IGC.0b013e3181990127 Deligdisch, 1999, Ovarian dysplasia in prophylactic oophorectomy specimens, Cancer, 86, 1544, 10.1002/(SICI)1097-0142(19991015)86:8<1544::AID-CNCR22>3.0.CO;2-I Deligdisch, 1997, Ovarian dysplasia: a review, Int J Gynecol Cancer, 7, 89, 10.1046/j.1525-1438.1997.00379.x Auersperg, 2002, Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches, Int J Gynecol Cancer, 12, 691, 10.1046/j.1525-1438.2002.01152.x Cramer, 1983, Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis, J Natl Cancer Inst, 71, 717 Dauplat, 2009, Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer, Eur J Cancer, 45, 2977, 10.1016/j.ejca.2009.06.012 Shushan, 1996, Human menopausal gonadotropin and risk of epithelial ovarian cancer, Fertil Steril, 65, 13, 10.1016/S0015-0282(16)58020-0 Mahdavi, 2006, Induction of ovulation and ovarian cancer: a critical review of the literature, Fertil Steril, 85, 819, 10.1016/j.fertnstert.2005.08.061 Chene, 2008, Ovarian epithelial dysplasia: myth or reality? Review, Gynecol Obstet Fertil, 36, 800, 10.1016/j.gyobfe.2008.05.003 Barakat, 2000, Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimen from BRCA1 heterozygotes, Cancer, 89, 383, 10.1002/1097-0142(20000715)89:2<383::AID-CNCR25>3.0.CO;2-T Deligdisch, 1999, Ovarian dysplasia in prophylactic oophorectomy specimens. Cytogenetic and morphometric correlations, Cancer, 86, 1544, 10.1002/(SICI)1097-0142(19991015)86:8<1544::AID-CNCR22>3.0.CO;2-I Deligdisch, 1989, Characterization of ovarian dysplasia by interactive morphometry, Cancer, 63, 748, 10.1002/1097-0142(19890215)63:4<748::AID-CNCR2820630424>3.0.CO;2-8 Deligdisch, 1993, Ovarian dysplasia: nuclear texture analysis, Cancer, 72, 3253, 10.1002/1097-0142(19931201)72:11<3253::AID-CNCR2820721120>3.0.CO;2-1 Brewer, 2005, Exploratory study of ovarian intraepithelial neoplasia, Cancer Epidemiol Biomarkers Prev, 14, 299, 10.1158/1055-9965.EPI-04-0212 Schloosshauer, 2003, Prophylactic oophorectomy, Cancer, 98, 2599, 10.1002/cncr.11848 Leunen, 2006, Prophylactic salpingo-oophorectomy in 51 women with familial breast-ovarian cancer: importance of fallopian tube dysplasia, Int J Gynecol Cancer, 16, 183, 10.1111/j.1525-1438.2006.00287.x Piek, 2001, Dysplastic changes in prophylactic removed fallopian tubes of women predisposed to developping ovarian cancer, J Pathol 2001, 195, 451 Crum, 2007, Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer, Clin Med Res, 5, 35, 10.3121/cmr.2007.702